Naproxen (Addition) -- Adults
Drug information
Section 2: NSAIMs and DMARDs 2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)
Formulation:
Tablet: 250 mg; 500 mg.
Application prepared by:
William Harvey Research Institute, Barts and The London School of Medicine and Dentistry and Institute for Clinical Evaluative Sciences, Toronto, Canada.